Novugen Pharma Became the First Pharmaceutical Company in Malaysia to Receive USFDA Approval for Its Manufacturing Facility

Novugen Pharma Became the First Pharmaceutical Company in Malaysia to Receive USFDA Approval for Its Manufacturing Facility

The Company was audited in September 2022 and USFDA issued an Establishment Inspection Report (EIR) in November 2022. Novugen Pharma is the first USFDA approved pharmaceutical manufacturing in Malaysia and the only in Southeast Asia. - November 22, 2022 - Novugen

Pregmune Joins Digital Twin Consortium

Pregmune is thrilled to announce that has recently joined the Digital Twin Consortium (DTC), a global initiative created with the goal to be The Authority in Digital Twin(TM) as it relates to policy, security, interoperability, and overall development of digital twins. Founded in 2020 by Dr. - November 17, 2022 - Pregmune

Virb Lands Contract with $10B Life Sciences Company

Virb Lands Contract with $10B Life Sciences Company

Begins Series A Financing to Accelerate Growth in the Clinical Research Industry. - November 16, 2022 - Virb

DataJoint Launches New Cloud-Based System for Automating Neuroscience Experiments

DataJoint Launches New Cloud-Based System for Automating Neuroscience Experiments

DataJoint's New Cloud Solution Improves Lab Efficiency and Accuracy - November 11, 2022 - DataJoint

New Pivotal Data Demonstrates Clinical Feasibility of GeneFluidics’ Direct-from-Specimen AST in Clinical Settings

New Pivotal Data Demonstrates Clinical Feasibility of GeneFluidics’ Direct-from-Specimen AST in Clinical Settings

GeneFluidics, Inc. is pleased to announce a joint publication with the Medical College of Wisconsin (MCW) that introduces rapid antimicrobial susceptibility testing (AST), which would represent a paradigm shift in the clinical management of microbial infections. The data from the MCW study have... - November 04, 2022 - GeneFluidics Inc.

DistillerSR Launches New CuratorCR Capabilities to More Dynamically Manage and Reuse Evidence-Based Research

CuratorCR Knowledge Center Provides Alternative to Elsevier’s QUOSA Virtual Library as Its Sunset Date Looms. - October 31, 2022 - DistillerSR

Huntington Study Group Announces Results from the HD-Net Assessment on the State of Care for Huntington’s Disease in the United States

Huntington Study Group Announces Results from the HD-Net Assessment on the State of Care for Huntington’s Disease in the United States

The Huntington Study Group (HSG), a world leader in clinical research for Huntington’s Disease (HD) for over 30 years, is pleased to announce the results from the novel HD-Net survey, which examined the United States Huntington’s disease (HD) care delivery in a variety of clinic settings by HD specialists and non-specialists. - October 25, 2022 - Huntington Study Group

Minus K Technology Announces Announces Its Seventh U.S. Educational Giveaway of Vibration Isolators to Colleges and Universities

As Minus K celebrates their upcoming 30 years in business, they are giving away $25,000* dollars worth of passive mechanical patented superior performing negative-stiffness low-frequency vibration isolators to colleges in the United States. - October 25, 2022 - Minus K Technology Inc.

Huntington Study Group Announces myHDstory™ Pilot Study: Making HD Voices Heard Has Reached Target Enrollment

Huntington Study Group Announces myHDstory™ Pilot Study: Making HD Voices Heard Has Reached Target Enrollment

The Huntington Study Group (HSG), a world leader in clinical research for Huntington’s Disease (HD) for over 30 years, is pleased to announce that the pilot study, Making HD Voices Heard, on the new online research platform, myHDstory™, has reached its enrollment target. “The HSG... - October 18, 2022 - Huntington Study Group

Huntington Study Group Enrolls First Participant for Its Observational Study to Test the Reliability of the Virtual Use of the Unified Huntington’s Disease Rating Scale

Huntington Study Group Enrolls First Participant for Its Observational Study to Test the Reliability of the Virtual Use of the Unified Huntington’s Disease Rating Scale

The Huntington Study Group (HSG), a world leader in conducting clinical trials for Huntington’s Disease (HD) for over 30 years, together with its Clinical Research Organization (“CRO”), the HSG Clinical Research, Inc., today announces the enrollment of the first participant of its... - October 12, 2022 - Huntington Study Group

SYNG Pharmaceuticals Announces Issuance of Its Canadian Patent for Non-Hormonal Therapy for Endometriosis

SYNG Pharmaceuticals Inc. (SYNG), a Kingston, Ontario based women’s health biotech, is pleased to announce that on October 04, 2022, the Canadian Intellectual Property Office granted Canada Patent No. 2,903,608 titled, "Treatment of endometriosis, angiogenesis and/or endometrial lesion growth." - October 09, 2022 - SYNG Pharmaceuticals Inc.

Zoo Media Debuts a Green Alternative to Plastic Bottles to Promote Zoos, Aquariums, and Fish Hatcheries

Zoo Media, the leading provider of smart advertising for zoos and aquariums in the U.S., is proud to introduce Pure Box Water: an earth-friendly, cardboard water container that supports maximum advertising of zoos, aquariums, and fish hatcheries and helps preserve America's land and wildlife. Dan... - September 30, 2022 - Zoo Media

Evidence Partners Rebrands as DistillerSR to Leverage Market Awareness of Its Core Literature Review Platform

The Company Also Bolstered Its Executive Team in Security, Product Management and Operations to Support Accelerating Growth - September 28, 2022 - DistillerSR

ALS Therapy Development Institute Announces Superior Rail & Iron Works, Inc. as First Title Sponsor of White Coat Affair Gala

ALS Therapy Development Institute Announces Superior Rail & Iron Works, Inc. as First Title Sponsor of White Coat Affair Gala

Superior Rail & Iron Works, Inc. will be the first Title Sponsor of the White Coat Affair gala, being held on October 15, 2022, at the Boston Sheraton to raise funds for ALS research. - September 28, 2022 - ALS Therapy Development Institute

New Decentralized Clinical Trial (DCT) Patient Satisfaction and Participation Report

800 Current and Future Clinical Trial Participants Link Satisfaction and Willingness to Participate with Decentralized Strategies - September 21, 2022 - Life Science Strategy Group, LLC

Virb to Collaborate with Tufts CSDD on CRA Roundtable on October 18, 2022

Virb to Collaborate with Tufts CSDD on CRA Roundtable on October 18, 2022

Event to focus on the connection between CRA experience and performance. - September 20, 2022 - Virb

Zoo Media Debuts a Green Alternative to Plastic Bottles to Promote Zoos in America

Zoo Media is elated to introduce Pure Box Water, an earth-friendly, cardboard water container that allows for maximum zoo advertising while playing a leading role in preserving America's land and wildlife. Dan Kost, Chief Executive Officer of Zoo Media, said, "The clever promotion will allow... - September 08, 2022 - Zoo Media

Paras Biopharmaceuticals Finland Oy Has Been Identified as One of the "Fastest Growing Companies in the Nordic Biotechnology Therapeutics & Diagnostics Industry"

Paras Biopharmaceuticals Finland Oy Has Been Identified as One of the "Fastest Growing Companies in the Nordic Biotechnology Therapeutics & Diagnostics Industry"

Paras Biopharmaceuticals is pleased to announce that the company has been identified as one of the Fastest Growing Companies in the Nordic Biotechnology Therapeutics and Diagnostics industry by Plimsoll Publishing UK. - September 01, 2022 - Paras Biopharmaceuticals Finland Oy

CABRI Announces Call for Proposals on Specialized Pro-Resolving Mediator Analytical Methods

The Cayman Biomedical Research Institute (CABRI) is offering research grants in amounts up to $100,000 to support essential research on specialized pro-resolving mediator (SPM) analytical methods. - August 26, 2022 - Cayman Chemical Company

Deadline Extended: CABRI Announces Undergraduate Fellowships and Scholarship Program

The Cayman Biomedical Research Institute (CABRI) is accepting applications from undergraduate students who have been offered an unpaid laboratory research position under an accredited principal investigator. Applications will be accepted from August 22 until September 18, 2022. - August 26, 2022 - Cayman Chemical Company

Hemanext Announces Publication of Hypoxic Blood Storage Study in Blood Advances

Research shows that hypoxic storage preserves faster oxygen unloading from red blood cells compared to standard conditions. - August 05, 2022 - Hemanext

Propper Manufacturing Company Awarded the Sterilization Assurance Agreement with Premier, Inc.

Propper Manufacturing Company has been awarded a group purchasing agreement for Sterilization Assurance with Premier, Inc. Effective October 1, 2022, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for... - August 04, 2022 - Propper Manufacturing Company

Tim Wintz and Jarett Greenside Promoted to Senior Vice Presidents of Radiology for NY Imaging Specialists

Tim Wintz and Jarett Greenside Promoted to Senior Vice Presidents of Radiology for NY Imaging Specialists

NY Imaging Specialists announced today the appointments of Tim Wintz and Jarett Greenside to Senior Vice Presidents of Radiology. - August 02, 2022 - New York Imaging Specialists

Team Arnav Foundation to Hold 3rd Annual Event

Team Arnav Foundation to Hold 3rd Annual Event

Public announcement telling folks to participate in a local event whose proceeds help eradicate pediatric osteosarcoma. - July 09, 2022 - Team Arnav Foundation

ReproTech, LLC Welcomes New President & CEO, William Braun

ReproTech, LLC Welcomes New President & CEO, William Braun

ReproTech, LLC, the industry leader in human reproductive tissue cryogenic storage, is pleased to announce that William J. Braun has been selected as ReproTech’s new President and Chief Executive Officer. Braun assumed the role on April 4, 2022, and will be based in ReproTech’s Coconut Creek, FL location. - July 09, 2022 - ReproTech, LLC

River Valley Relief Names Ryan Kenaga President

River Valley Relief (RVR), a family-owned medical cannabis cultivator located in Fort Smith, Arkansas makes some organizational changes and names new President. - July 08, 2022 - River Valley Relief

Global Cancer Technology Successfully Concludes Glioblastoma Pre-Clinical Animal Studies with Impressive Results

Global Cancer Technology Successfully Concludes Glioblastoma Pre-Clinical Animal Studies with Impressive Results

Global Cancer Technology, a San Diego, CA biotechnology company, has successfully completed animal testing with GCT.GLIO.1, a PI3K selective inhibitor that can cross the blood brain barrier and modulate immune cell function. The company will advance the compound to Phase 1 clinical trials as a next step. - July 08, 2022 - Global Cancer Technology

Hemanext Announces Appointment of Daan Kok as the Executive Vice President & General Manager of Hemanext for Europe, Middle East, and Africa

Hemanext Inc. (“Hemanext” or the “Company”), a leading innovator in blood processing and storage technology, today announced the appointment of Daan Kok as the Executive Vice President & General Manager of Hemanext for Europe, Middle East and Africa (EMEA). In his role,... - July 05, 2022 - Hemanext

Defined Bioscience Announces Formation of Scientific Advisory Board

Defined Bioscience, a life science tools company pioneering the development of next generation ingredients for cell culture, today announced the formation of its scientific advisory board (SAB). The SAB is comprised of a distinguished group of academic and industry experts who will advise the... - June 15, 2022 - Defined Bioscience Inc.

HealthWare Systems Expands Services

HealthWare Systems meets evolving client needs with healthcare automation solutions, RPA, and services divisions – CredentialingOne & EligibilityAdvocates. - June 10, 2022 - HealthWare Systems

Eledon Announces Phase 2a Trial Results of Tegoprubart (AT-1501) – a Drug Invented at ALS TDI

Eledon Announces Phase 2a Trial Results of Tegoprubart (AT-1501) – a Drug Invented at ALS TDI

Eledon Pharmaceuticals announced topline results from their Phase 2 trial of tegoprubart (formerly AT1501), a drug invented and developed at the ALS Therapy Development Institute (ALS TDI). The Phase 2a trial in ALS was a 12-week, open label, dose escalating, safety, and biomarker study. The... - May 31, 2022 - ALS Therapy Development Institute

ALS Therapy Development Institute Scientists to Present Posters Sharing Research Advancements at the ALS Drug Development Summit

ALS Therapy Development Institute Scientists to Present Posters Sharing Research Advancements at the ALS Drug Development Summit

The ALS TDI scientists will be showcasing significant advancements in ALS research through multiple poster presentations. These posters will cover pre-clinical research exploring potential new therapeutic drug-like molecules and targets for ALS, as well as translational research analyzing patient data to identify new ALS biomarkers, drug targets, and patient populations. - May 25, 2022 - ALS Therapy Development Institute

Pharmaceutical Compliance Partners Selects Luke Forman, University of Notre Dame, for Summer Internship Program

Pharmaceutical Compliance Partners Selects Luke Forman, University of Notre Dame, for Summer Internship Program

Pharmaceutical Compliance Partners selected Luke Forman, a Science-Business major at University of Notre Dame, as its first summer intern. This is the inaugural year for Pharmaceutical Compliance Partners’ internship program, allowing students to learn about drug development, pharmaceutical compliance, and business operations of life sciences firms. - May 25, 2022 - Pharmaceutical Compliance Partners

ASAcampus Involved Once Again in an Experiment That Will Take Place on the International Space Station

The experiment, selected by the European Space Agency in the ESA-ILSRA2014 call and with the support of the Italian Space Agency (C-ASI N. 2018-14-U.0-Suture in Space), aims to study the process of surgical wound healing in space. - May 22, 2022 - ASA srl

Biopharma Industry Standout Robert Proulx Joins Advisory Board of Global Cancer Technology

Biopharma Industry Standout Robert Proulx Joins Advisory Board of Global Cancer Technology

Global Cancer Technology is developing innovative treatments for deadly diseases like cancer, with a current focus on glioblastoma and breast cancer. To date, Mr. Robert Proulx has held numerous Board positions, is a recognized thought leader in biopharma, and currently holds dual roles as the founder and CEO of Imagion Biosystems. - May 21, 2022 - Global Cancer Technology

LifeBiotic's Botanical Formula Shows Significant Destruction of Multiple GI Cancer Cells

In a new cell model study, the patented LCS101 formula eliminated up to 90% of cancer cells within 72 hours. - May 19, 2022 - Lifebiotic

The ALS TDI Discovery Biology Suite Dedicated in Honor of Liz Bodine to Speed Drug Development in ALS

The ALS TDI Discovery Biology Suite Dedicated in Honor of Liz Bodine to Speed Drug Development in ALS

The ALS Therapy Development Institute (ALS TDI) and Augie’s Quest to Cure ALS are proud to honor the commitment of Liz Bodine to facilitate more effective ALS drug discovery at ALS TDI, the world’s most comprehensive drug discovery lab dedicated solely to ALS. - May 04, 2022 - ALS Therapy Development Institute

Cyclists Support ALS Research with 3-Day, 270-Mile Ride from Boston to Greenwich in Tri-State Trek

Cyclists Support ALS Research with 3-Day, 270-Mile Ride from Boston to Greenwich in Tri-State Trek

Hundreds of riders to join the ride to end ALS this June and raise funds for cutting-edge ALS research. ALS TDI has received a $100,000 match for all donations made to the Tri-State Trek through the month of May. - May 03, 2022 - ALS Therapy Development Institute

“Fight ALS Film Fest” Aims to Shine a Spotlight on the World of ALS

Films explore universal themes of life-changing diseases through examination of ALS. Films and dialogue aim to improve understanding, uplift those affected, and expand the community. - April 25, 2022 - ALS Therapy Development Institute

American Laboratory Products Company Merges with GeneProof

American Laboratory Products Company, Ltd. (“ALPCO”), a specialty in vitro diagnostics company, today announced a merger with GeneProof a.s. (“GeneProof”), a leading molecular diagnostics company based in Brno, Czech Republic. The combination creates a global market leader... - April 21, 2022 - ALPCO

River Valley Relief Launches Relief by RVR Line of Marijuana Concentrates

River Valley Relief Launches Relief by RVR Line of Marijuana Concentrates

Arkansas has always been a state known for finding diamonds; just maybe not the kind that are coming out of Fort Smith recently. River Valley Relief Cultivation (“RVR”) has been hard at work producing live diamonds, among other live resin extracts, that were released to many Arkansas... - April 15, 2022 - River Valley Relief

Dr. Claudia C. Cotca of C3 Think Tank Appointed as Advisor Chair of Advanced Technology Academic Research Center (ATARC) on Digital AI & Data Analytics Warfighter Health

Dr. Claudia C. Cotca of C3 Think Tank appointed as Advisor Chair of Advanced Technology Academic Research Center (ATARC) on Digital AI & Data Analytics Warfighter Health. Together with leadership and military health experts, stakeholders and program officers, Dr. Claudia C Cotca will help support and contribute to the scope and mission of ATARC’s Warfighter Health in incorporating responsibly artificial intelligence in military medicine. - April 13, 2022 - C3 Think Tank

CredentialingOne – New Credentialing Outsourcing Company Powered by HealthWare Systems

The credentialing outsourcing company CredentialingOne combines HealthWare Systems automation technology with the expertise of Credentialing Specialists. - April 10, 2022 - HealthWare Systems

Degree Controls Integrates Airflow Monitors and Calibrated Anemometers

Degree Controls integrates airflow monitors and calibrated anemometers for fume hood certification using automated entry of face velocity measurements. - April 09, 2022 - Degree Controls

New Product for Solar Cells from Solaris Chem (Canada)

Solaris Chem expands its product offering for solar cell applications. - March 19, 2022 - Solaris Chem Inc.

Solaris Chem Products Are Now Available in Germany Through Hözel

Their distribution partner in Germany, Hözel, has included Solaris Chem's products to its range for the biotechnology sector. Hözel has been a well-established company since its foundation in 1993. Thanks to its long-standing market presence, it has a lot of experience and knowledge in... - March 19, 2022 - Solaris Chem Inc.

ALPCO Announced Its Support of the Ukrainian People in a Company-Wide Communication to Its Employees

ALPCO (Salem, NH) announced its support of the Ukrainian people in a company-wide communication to its employees. The message outlined the company's contribution to aid refugees through the American Red Cross and Project Hope in the amount of $5,000 each. Additionally, ALPCO is offering an... - March 16, 2022 - ALPCO

FOXG1 Research Foundation Hosts Napa Valley Charity Golf Tournament to Accelerate Research for Pediatric Neurological Disorder

FOXG1 Research Foundation Hosts Napa Valley Charity Golf Tournament to Accelerate Research for Pediatric Neurological Disorder

Scientists believe FOXG1 may hold the key to unlocking brain disorders affecting millions, including autism, Alzheimer’s, brain tumors and more. - February 23, 2022 - FOXG1 Research Foundation

American Society for Clinical Laboratory Science Missouri Presents Medical Laboratory Professionals Week

The American Society for Clinical Laboratory Science – Missouri (ASCLS-MO) is proud to present Medical Laboratory Professionals Week (MLPW). The clinical laboratory professional is a key member of today’s health care team. Laboratory professionals have the skills to unlock important... - February 21, 2022 - American Society for Clinical Laboratory Science Missouri

Degree Controls Adds BACnet® Airflow Sensor with Color Touch Screen to Its Suite of Airflow Monitors

Degree Controls launched Sensor200, the first BACnet® airflow sensor with color touch screen for facility managers to achieve local and remote communication. - February 08, 2022 - Degree Controls

Press Releases 1 - 50 of 2,211